Advertorial

Sartorius Stedim Biotech – offering innovative single-use technologies for advanced bioprocessing

Posted: 30 August 2019 | | No comments yet

Innovations in single-use process automation are driving single-use adoption into commercial biologics facilities. Here, Sartorius Stedim Biotech (SSB) shares its latest service offering.

What bioprocessing technology, and specifically single-use solutions, does your company offer? 

SSB provides the industry’s most comprehensive portfolio of single-use technologies and services adapted to the majority of bioprocessing needs, including end-to-end upstream and downstream processing of monoclonal antibodies (mAbs), vaccines, antibody-drug conjugates (ADCs) and regenerative medicines up to commercial scales.











To read this Guide to in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsor: Sartorius Stedim Biotech

Related organisations

Send this to a friend